AU2022311780A1 - Methods and compositions for improving visual function in ocular diseases and disorders - Google Patents

Methods and compositions for improving visual function in ocular diseases and disorders Download PDF

Info

Publication number
AU2022311780A1
AU2022311780A1 AU2022311780A AU2022311780A AU2022311780A1 AU 2022311780 A1 AU2022311780 A1 AU 2022311780A1 AU 2022311780 A AU2022311780 A AU 2022311780A AU 2022311780 A AU2022311780 A AU 2022311780A AU 2022311780 A1 AU2022311780 A1 AU 2022311780A1
Authority
AU
Australia
Prior art keywords
peptide
composition
pharmaceutically
eye
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022311780A
Other languages
English (en)
Inventor
Constance I. CHANG
David A. ESPOSITO
Lindsay M. GODSEY
David KLEINMAN
Andrew J. KOCAB
Sushanta Mallick
Jana Van De Goor
David N. Zacks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ONL Therapeutics Inc
Original Assignee
ONL Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ONL Therapeutics Inc filed Critical ONL Therapeutics Inc
Publication of AU2022311780A1 publication Critical patent/AU2022311780A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU2022311780A 2021-07-13 2022-07-12 Methods and compositions for improving visual function in ocular diseases and disorders Pending AU2022311780A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163221329P 2021-07-13 2021-07-13
US63/221,329 2021-07-13
US202263336896P 2022-04-29 2022-04-29
US63/336,896 2022-04-29
PCT/US2022/036830 WO2023287794A2 (en) 2021-07-13 2022-07-12 Methods and compositions for improving visual function in ocular diseases and disorders

Publications (1)

Publication Number Publication Date
AU2022311780A1 true AU2022311780A1 (en) 2024-02-08

Family

ID=84919637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022311780A Pending AU2022311780A1 (en) 2021-07-13 2022-07-12 Methods and compositions for improving visual function in ocular diseases and disorders

Country Status (5)

Country Link
US (2) US20240299488A1 (https=)
EP (1) EP4370208A4 (https=)
JP (1) JP2024525805A (https=)
AU (1) AU2022311780A1 (https=)
WO (1) WO2023287794A2 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010102052A2 (en) * 2009-03-03 2010-09-10 The Regents Of The University Of Michigan Methods of inhibiting photoreceptor apoptosis
US10508134B2 (en) * 2015-05-01 2019-12-17 Onl Therapeutics, Inc. Peptide compositions and methods of use

Also Published As

Publication number Publication date
US20240299488A1 (en) 2024-09-12
WO2023287794A2 (en) 2023-01-19
EP4370208A2 (en) 2024-05-22
US20240197815A1 (en) 2024-06-20
WO2023287794A3 (en) 2023-04-06
JP2024525805A (ja) 2024-07-12
EP4370208A4 (en) 2025-05-14

Similar Documents

Publication Publication Date Title
AU2021286278C1 (en) Methods for treating ocular diseases
KR102724014B1 (ko) 안 질환의 치료 방법
JP7725540B2 (ja) 眼の感染症および疾患を処置するための組成物および方法
US20130190278A1 (en) Compounds for the Treatment/Prevention of Ocular Inflammatory Diseases
US9155745B2 (en) Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs
EP4630031A2 (en) Methods and compositions for improving visual function in ocular diseases and disorders
TW202038966A (zh) 包含熊去氧膽酸之老花眼之治療或預防劑
US20240156898A1 (en) Methods and compositions for treating ocular disorders and diseases
US20240299488A1 (en) Methods and compositions for improving visual function in ocular diseases and disorders
CN117957010A (zh) 改善眼部疾病和病症中视功能的方法和组合物
US20250360123A1 (en) Methods and compositions for treating inherited retinal degeneration
JP2025541152A (ja) 眼病変を処置するための方法および組成物
WO2025184235A1 (en) Methods and compositions for treating glaucoma
WO2024220669A1 (en) Methods and compositions for treating rnfl thinning
CN115298206A (zh) 眼科药物组合物及其用途